会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COILED LADDER STENT
    • 绞线梯子
    • WO2006031285A2
    • 2006-03-23
    • PCT/US2005/024539
    • 2005-07-11
    • VASCULAR ARCHITECTS, INC.OLSON, Jonathan, M.ROSARIO, Peter, E.RAVICHANDRAN, GuruswamiTSURUDA, Marshall
    • OLSON, Jonathan, M.ROSARIO, Peter, E.RAVICHANDRAN, GuruswamiTSURUDA, Marshall
    • A61F2/06
    • A61F2/88A61F2/91A61F2/915A61F2002/9155
    • A coiled ladder stent (12) comprises side rails (14, 16) and rungs (18) connecting the rails. At least one rung has lower strength portion (24) or is an enhanced flexibility (28) rung, or both. The lower strength portion is positioned at a reduced strength fracture location (26) along the rung so to promote any fracture of the ladder stmt at the fracture location along the rung to help prevent fracture of a rail. One way to make the lower strength portion is to make the cross-sectional area of the lower strength portion less than the average cross-sectional area of the rung. The enhanced flexibility aspect helps to accommodate relative movement between the side rails. Doing so helps to prevent fracture of the rails and rungs. In some embodiments of the invention the enhanced flexibility rung comprises one or more nonlinear, such as generally S-shaped or generally U-shaped, portions.
    • 螺旋式梯架(12)包括侧轨(14,16)和连接轨道的梯级(18)。 至少一个梯级具有较低的强度部分(24)或是增强的柔性(28)梯级,或两者。 较低强度部分位于沿着梯级的减小的强度断裂位置(26)处,以便促进沿着梯级的断裂位置处的梯子桩的任何断裂,以有助于防止轨道断裂。 制造低强度部分的一种方式是使下部强度部分的横截面面积小于横梁的平均横截面面积。 增强的灵活性方面有助于适应侧轨之间的相对运动。 这样做有助于防止轨道和梯级断裂。 在本发明的一些实施例中,增强的柔性梯级包括一个或多个非线性,例如大致S形或大致U形的部分。
    • 3. 发明申请
    • COVERED STENT WITH CONTROLLED THERAPEUTIC AGENT DIFFUSION
    • 覆盖支架控制治疗药物扩散
    • WO2006031284A2
    • 2006-03-23
    • PCT/US2005/024183
    • 2005-07-11
    • VASCULAR ARCHITECTS, INC.IKI, KobiTSURUDA, Marshall
    • IKI, KobiTSURUDA, Marshall
    • A61F2/06
    • A61F2/91A61F2/88A61F2250/0068
    • A covered stent (18) includes a generally tubular stent body (16) having inner and outer stent body surfaces (26, 24). A sleeve of porous material (20) encloses the stent body and has inner and outer portions (40, 42) opposed to the inner and outer stent body surfaces. A therapeutic agent is located along the stent body, the agent being diffusible through the material. A diffusion barrier (30) is located between the inner material portion and the agent along the stent. The diffusion barrier prevents passage of at least a significant amount the agent through the inner portion of the sleeve of porous material. A diffusion restrictor (32) is located between the outer portion of the sleeve of porous material and the agent along the stent. The diffusion restrictor permits passage of the agent through the inner material portion at a therapeutic level.
    • 覆膜支架(18)包括具有内支架主体表面(26)和外支架主体表面(24)的大致管状支架主体(16)。 多孔材料的套管(20)包围支架主体,并具有与内部和外部支架主体表面相对的内部和外部(40,42)。 治疗剂沿着支架体定位,该试剂可扩散穿过材料。 扩散屏障(30)沿支架位于内部材料部分和制剂之间。 扩散阻挡层防止至少显着量的试剂通过多孔材料套筒的内部部分。 扩散限制器(32)位于多孔材料套管的外部与沿着支架的制剂之间。 扩散限制器允许药剂以治疗水平通过内部材料部分。